Pregled bibliografske jedinice broj: 1108263
“Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide” on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news
“Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide” on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news // European Journal of Nuclear Medicine and Molecular Imaging, 47 (2020), 6; 1342-1344 doi:10.1007/s00259-020-04748-4 (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 1108263 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
“Quid autem vides festucam in oculo fratris tui et
trabem in oculo tuo non vide” on the
hyperthyroidism-induced mortality and antithyroid
drug-induced side effects in the era of
radioiodine fake news
Autori
Giovanella, Luca ; Verburg, Frederik A. ; Petranović Ovčariček, Petra ; Iakovou, Ioannis ; Mihailovic, Jasna ; Vrachimis, Alexis ; Zerdoud, Slimane ; Hoffmann, Martha ; Luster, Markus
Izvornik
European Journal of Nuclear Medicine and Molecular Imaging (1619-7070) 47
(2020), 6;
1342-1344
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
radioiodine, hyperthyroidism, mortality, antithyroid drugs
Sažetak
Radioactive iodine (RAI) is widely used to treat patients with Graves’ disease, as either initial therapy or following failure of thionamides, and thyroid nodular autonomy. The recent publication of a study from Kitahara and colleagues, indicating a slightly higher relative risk of breast cancer in hyperthyroid patients receiving RAI therapy, started a large debate that is mainly focused on methodological limitations. Quite surprisingly, two of Kitahara’s study co-authors showed, using data from the same cohort, that the standardized mortality ratio (SMR) for breast cancer is higher for patients treated with antithyroid drugs compared with patients treated with RAI.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE